FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On October 19, 2006
Table of Contents
Docket # Title
1988N-0258 Prescription Drug Marketing Act of 1987; Guideline
1992N-0297 Prescription Drug Marketing Act of 1987, Drug Amds of 1992
2003N-0312 Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds
2005D-0169 Guidance on Useful Written Consumer Medication Information (CMI)
2005D-0202 Guidance for Industry on Bar Code Label Requirements; Questions and Answers
2006D-0226 Prescription Drug Marketing Act Pedigree Requirements under 21 CFR Part 203; Effective Date and Compliance Policy GuideProgram, Draft Guidance; Availability
2006FL-0384 Food Allergen Labeling Petition (FALP): Soy lecithin when used as processing aids
2006N-0107 FDA-Regulated Products Containing Nanotechnology Materials
2006N-0292 Unique Device Identification
2006N-0352 Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
2006P-0390 Order the Church of Scientology to clearly disclose the potential health hazards inherent in the use of the E-meter and Scientology's practice of "auditing"
2006P-0394 Revise the labeling requirements for eggs sold in the United States
2006P-0422 Refrain from approval of any Abbreviated New Drug Application (ANDA) for metoprolol succinate extended release 100 mg and 200 mg tablets subsequent to ANDA 76-640 from KV Pharmaceutical Company
1988N-0258 Prescription Drug Marketing Act of 1987; Guideline
C 141 STAT Pharmaceuticals, Inc. Vol #: 6
C 142 STAT Pharmaceuticals, Inc. Vol #: 6
1992N-0297 Prescription Drug Marketing Act of 1987, Drug Amds of 1992
C 134 STAT Pharmaceuticals, Inc. Vol #: 10
C 135 STAT Pharmaceuticals, Inc. Vol #: 10
2003N-0312 Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds
EC 26 Mrs. Nancy Malmberg Vol #: 8
2005D-0169 Guidance on Useful Written Consumer Medication Information (CMI)
EC 23 Mr. david lowe Vol #: 2
2005D-0202 Guidance for Industry on Bar Code Label Requirements; Questions and Answers
EC 6 Endodontic Associates Vol #: 1
2006D-0226 Prescription Drug Marketing Act Pedigree Requirements under 21 CFR Part 203; Effective Date and Compliance Policy GuideProgram, Draft Guidance; Availability
C 8 STAT Pharmaceuticals, Inc. Vol #: 1
C 9 STAT Pharmaceuticals, Inc. Vol #: 1
2006FL-0384 Food Allergen Labeling Petition (FALP): Soy lecithin when used as processing aids
CP 1 The Solae Company Vol #: 1
2006N-0107 FDA-Regulated Products Containing Nanotechnology Materials
EC 21 Environmental Working Group Vol #: 12
2006N-0292 Unique Device Identification
EC 27 VDDI Association of German Dental Industry Vol #: 1
EC 28 VDDI Association of German Dental Industry Vol #: 1
2006N-0352 Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
EC 83 Mr. Peter Wood Vol #: 3
2006P-0390 Order the Church of Scientology to clearly disclose the potential health hazards inherent in the use of the E-meter and Scientology's practice of "auditing"
EC 5 Mr. Noel Cower Vol #: 1
EC 6 Dr. Donna Shannon Vol #: 1
2006P-0394 Revise the labeling requirements for eggs sold in the United States
EC 174 Mrs. Tonia Hightower Vol #: 2
EC 175 Miss. April Stacy Vol #: 2
EC 176 Miss. Taylor Barton Vol #: 2
EC 177 Ms. DEBORAH SMITH Vol #: 2
EC 178 Ms. marian turczyn Vol #: 2
EC 179 Ms. Julie Eyrich Vol #: 2
EC 180 Ms. Rachael Pream Grenier Vol #: 2
EC 181 Ms. Rebecca Vick Vol #: 2
EC 182 Miss. Kristi Lehman Vol #: 2
EC 183 Miss. Heidi Goss Vol #: 2
EC 184 Mr. Ron Scheinberg Vol #: 2
EC 185 Dr. Edward Butler Vol #: 2
EC 186 Miss. Katie Prock Vol #: 2
EC 187 Mr. David Scholtz Vol #: 2
EC 188 Ms. Allison Shurilla Vol #: 2
EC 189 Ms. Julie Rothman Vol #: 2
EC 190 Mr. Ricardo Moreira Vol #: 2
EC 191 Mrs. Sandy Mielo Vol #: 2
EC 192 Mr. Todd Snyder Vol #: 2
EC 193 Mr. Max Green Vol #: 2
EC 194 Mr. Andrew Zollman Vol #: 2
EC 195 Sonoma people For ANIMAL Rights Vol #: 2
EC 196 Ms. Purvi Jani Vol #: 2
EC 197 Mrs. Susan Clay Vol #: 2
EC 198 Dr. Sam Becker Vol #: 2
EC 199 Mr. Ronnie Rizo Vol #: 2
EC 200 Ms. Carolyn Counts Vol #: 2
EC 201 Ms. Amity Neumeister Vol #: 2
EC 202 Mrs. Kendra Knight Vol #: 2
EC 203 Miss. celine rousseau Vol #: 2
EC 204 Mr. David Reisman Vol #: 2
EC 205 Miss. Heather Gainer Vol #: 2
EC 206 Mr. Laveen Venugopalan Vol #: 2
EC 207 Mr. Robert L Foley Jr Vol #: 2
EC 208 Ms. Anne Dudfield Vol #: 2
EC 209 Ms. Andi Morgan Vol #: 2
EC 210 Mrs. Deb Kovacs Vol #: 2
EC 211 Mrs. Mary Morrison Vol #: 2
EC 212 Mr. Stanley Charles Vol #: 2
EC 213 Ms. Kathleen Merlo Vol #: 2
EC 214 Mrs. Jennifer Carlson Vol #: 2
EC 215 Ms. Tamara Abashian Vol #: 2
EC 216 Miss. Jeanette Holmgren Vol #: 2
EC 217 Ms. Diane Murphy Vol #: 2
EC 218 Ms. Tracey Glover Vol #: 2
EC 219 Mrs. Stephanie Seymour Vol #: 2
EC 220 Miss. Jodi Chemes Vol #: 2
EC 221 Ms. Heather Halvorson Vol #: 2
2006P-0422 Refrain from approval of any Abbreviated New Drug Application (ANDA) for metoprolol succinate extended release 100 mg and 200 mg tablets subsequent to ANDA 76-640 from KV Pharmaceutical Company
CP 1 KV Pharmaceutical Company Vol #: 1

Page created on October 23, 2006 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management